Adaptive Learning to Improve Individualized Management of Type 2 Diabetes (T2D)
As a primary care provider, you play a critical role in the management of patients with type 2 diabetes. ACHL AdaptED® offers a unique experience designed to meet the needs of busy clinicians seeking to enhance their expertise in this area. Our adaptive learning platform allows you to tailor your educational experience to match your specific learning goals and knowledge gaps. This activity has ...
|
|
Advances in Neurostimulation for Managing Chronic Post-Amputation Pain
Everything about chronic post-amputation pain (CPAP) is complex: from its disparate pathophysiological mechanisms to complex treatment approaches. Join leading pain management expert, Leonardo Kapural, MD, PhD, and vascular surgeon, Billy Kim, MD, FACS, as they discuss the management of CPAP complexities and insufficiencies of the current therapeutic landscape, as well as emerging evidence on no...
|
|
Answers to the Questions You May Not be Asking: Treating Ulcerative Colitis Considerate of Patient-Centric Factors
Are you aware of the latest evidence-based strategies in ulcerative colitis (UC)? Looking to expand your ability to incorporate patient-centric factors into selection of therapy for UC? Navigate through this novel, interactive self-directed activity designed to optimize your decision making in selection of therapy for UC. View expert perspectives and insights who can help you apply newer strate...
|
|
Are You Seeing the Whole Picture? Test Your Skills for Intensifying Therapy in Patients with Type 2 Diabetes
The management of type 2 diabetes (T2D) has evolved rapidly with new agents and changing recommendations. Do you see the whole picture when selecting therapy for your patients? Engage in this interactive clinical case challenge to see whether your treatment selection aligns with guideline recommendations and account for cardiovascular disease risks, patient-centric factors, and weight manageme...
|
|
Co-Management of Severe Asthma: Improving Processes for Primary Care Assessment and Referral to Specialty Care through Quality Improvement
Can you recognize severe asthma? Our easy-to-administer digital quality improvement (QI) program walks you through steps to assess how well your clinical practices align with evidence-based practice, allows you to select goals to address your identified gaps, dynamically creates an action plan for you or your team, and offers pre-developed interventions to achieve these goals. QI doesn't ha...
|
|
Dermatology Clinical Case Challenge: Can You Diagnose this Patient?
How are your diagnostic skills for identifying inflammatory skin conditions? In just 10 minutes, learners navigate through three real-world cases and respond to questions relative to possible next steps in diagnostic procedures considerate of each patient’s history and perspective, physical examination findings, lab results, and skin biopsy results. Diagnostic conclusions are revealed after re...
|
|
Developing Optimal Strategies for Reducing Morbidity in Patients with Non-Cystic Fibrosis Bronchiectasis
This case-based morbidity and mortality review (MMR) assesses the negative implications of suboptimal therapeutic management for patients with non-cystic fibrosis bronchiectasis. Cases and expert discussion focus on ensuring a prompt and accurate diagnosis of bronchiectasis, understanding the benefits of high frequency chest wall oscillation (HFCWO), and identifying patients who can benefit from...
|
|
Emerging Therapies, Novel Mechanisms, and New Hope in the Treatment of PAH
The treatment landscape of pulmonary arterial hypertension (PAH) is poised to change dramatically in the near future. Designed with your questions in mind, this digital FAQ index offers succinct and relevant information for all practicing pulmonology and cardiology learners. What are some of the emerging therapies for PAH, and how do they differ from current treatment options? Which emerging the...
|
|
Expanding the Benefit of Quality Improvement Programs: Sustainable Solutions to Achieve Therapeutic Goals for Patients with Myelofibrosis
Achieve measurable changes to improve your patients’ outcomes with this simple, systematic approach for quality improvement for application at any practice setting. Complete an assessment to understand where your practice’s performance falls relative to identified goals, which guides development of personalized action items. Access the framework and tools you need to measure your understandi...
|
|
How I Treat Paroxysmal Nocturnal Hemoglobinuria (PNH)
In this point-counterpoint digital activity, two expert faculty discuss and debate treatment selection for patients with PNH through case-based scenarios. Faculty review mechanisms of action, clinical trial data, and real-world evidence supporting divergent treatment strategies for the presented cases. How do the experts make their initial treatment selections? Why might they choose a C5 inhibit...
|
|
Improving Diagnosis and Management of Chronic Idiopathic Constipation Across Diverse Patient Populations
Can you differentiate between chronic idiopathic constipation (CIC) and other conditions characterized by constipation to ensure your patients receive timely and appropriate interventions? Access these educational resources and tools to help you enhance diagnostic processes, management strategies, and multidisciplinary care. Then share this invaluable educational content with your team by using ...
|
|
Improving Processes for Primary Care Assessment and Referral to Specialty Care in Severe Asthma
Can you recognize severe asthma? Access these educational resources and tools to help you enhance assessment and diagnostic practices and introduce guideline-recommended referral processes. Then share this invaluable educational content with your team by using the downloadable slide decks and discussion guides to initiate meaningful conversations and improve interprofessional care. And to assis...
|
|
Individualized Strategies for Relapsed/Refractory Multiple Myeloma: Navigating Complexity with BCMA-Targeted and Novel Bispecific Antibodies
The expanding armamentarium of therapies for R/R MM shifts therapy selection from an algorithmic approach to an individualized strategy that requires consideration of the nature of relapse, prior therapies, treatment-related toxicities, as well as patient comorbidities and preferences. With the introduction of novel bispecific antibodies, specialists must learn how to optimally sequence these th...
|
|
It Takes a Village: Working Together to Reduce Racial Inequities in Maternal Morbidity and Mortality
Maternal morbidity and mortality rates are unacceptably high in the United States (US). In fact, Black women are two to three times more likely to die from pregnancy-related causes than white women, prompting the US Department of Health and Human Services to state that maternal deaths are a public health crisis. What can you do to address these inequities in maternal health? Two experts in this ...
|
|
Multidisciplinary Strategies to Prevent Hospitalization in Patients with Worsening Heart Failure
Despite guideline-directed medical therapy, many patients with heart failure (HF) with reduced ejection fraction continue to experience worsening HF and hospitalizations. As such, it is incumbent upon clinicians to improve familiarity and competence with available therapies and clinical trial data that may guide patient selection to individualize and optimize therapy for patients with HF. In thi...
|
|
New Conversations About Long-Acting Reversible Contraceptives: Patient Stories and Expert Reflections
Despite having the highest rates of effectiveness amongst contraceptives, few women in the U.S. use long-acting reversible contraceptives (LARCs), placing them at risk of unintended pregnancies. Myriad of clinician, systemic, and patient factors contribute to low rates of use. Education on the appropriate use of LARCs along with proper insertion techniques has been demonstrated to increase their...
|
|
Parenteral Nutrition Solutions: Developing a Playbook for the Multidisciplinary Team
In these symposium highlights, a multidisciplinary panel of experts discuss a range of topics, including the role of indirect calorimetry, protein requirements, intravenous lipid emulsions, and the nutrition support team. Also highlighted are a real-world patient case and the questions and answers/panel discussion. An accompanying infographic on the importance of the nutrition support team and h...
|
|
Pathways for Optimal Sequencing, Rapid Initiation, and Titration of Therapy in Patients with Heart Failure
Many patients with heart failure (HF) do not receive foundational treatment although these therapies reduce morbidity and mortality risks. The initiation and optimization of guideline-directed medical therapies (GDMT) can be challenging, but clinical practice guidelines and algorithms are available to assist.
Navigate through this interactive self-directed CME activity to apply the most recen...
|
|
Pathways to Developing Personalized Treatment Regimens for Patients with Advanced Melanoma
No two patients with advanced melanoma are the same and tailoring treatment is vital. Immerse yourself in this interactive “choose your path” digital algorithm with expert perspectives to assist with the application of new guidelines and treatment options to optimize therapy.
Do you have questions about treating patients with advanced melanoma? Do you wonder…
• When to use immune ch...
|
|
Ready for a Closeup: Differentiating Inadequate Response and Emotional Blunting During Treatment for Major Depressive Disorder
Major depressive disorder (MDD) can have a significant impact on your patients’ lives. However, MDD is not just about feeling “down.” It’s a life-threatening condition that is a leading cause of suicide. Fortunately, there are a variety of effective therapies; however, many patients may experience an inadequate response to treatment and others may have experience anhedonia or reduced emo...
|
|
Simple Steps for Improving the Quality of Healthcare for Patients with Chronic Idiopathic Constipation
To ensure your patients with chronic idiopathic constipation (CIC) receive timely, appropriate interventions and the best possible care, clinicians need to better distinguish CIC from similar conditions. In addition, working together, clinicians and patients can make better choices among the many treatment options through shared decision-making (SDM) strategies to help achieve treatment goals.
...
|
|
State-of-the-Art Obesity Management in the Primary Care Setting
Access our robust online slide library covering the management of obesity in the primary care setting. Expert faculty in weight management developed content related to epidemiology, pathophysiology, and complications of obesity; screening and diagnosis; patient counseling; case studies; nonpharmacologic therapies; and pharmacologic therapies. Choose your topic interests and customize your own sl...
|
|
Sustainable Solutions to Achieve Therapeutic Goals for Patients with Myelofibrosis
When it comes to treating your patients with myelofibrosis (MF), are you applying the latest guidance in practice? Evidence shows that it takes an average of 17 years for evidence to change practice but how can we incorporate treatment advances to improve patient outcomes today? This activity looks to bridge the chasm between education and implementation by framing available evidence and guideli...
|
|
The Critical Role of Managed Care Pharmacists in Optimizing Treatment of Iron Deficiency in Patients with Heart Failure
Despite evidence-based interventions to prevent or manage heart failure (HF), poor HF-related outcomes persist as evidenced by the number of preventable HF-related hospitalizations and high readmission rates. Moreover, the economic burden that HF places on the health care system is significant. Pharmacists can improve adherence to guideline recommendations for the use of intravenous (IV) iron th...
|
|
The Pharmacist’s Role in Managing Patients with Worsening Heart Failure
Pharmacists play a vital role in the management of patients with heart failure (HF). Navigate through this interactive self-directed, pharmacist-targeted activity designed to optimize your decision-making to apply the most recent clinical trial data and guidance seen in real-world HF practice, particularly in patients with worsening HF and after recent HF hospitalization. Expert perspectives and...
|
|
Therapeutic Advancements for the Treatment of High-Risk MDS: Future Opportunities to Improve Patient Survival and Quality of Life
Stay up to date on the evolving risk classification for myelodysplastic syndromes (MDS) and current treatment guidelines for patients with high-risk disease in this self-directed education with leading oncology experts. Expert commentary from Courtney DiNardo, MD from MD Anderson Cancer Center and Dr. Dan Pollyea from the University of Colorado School of Medicine provides insights on emerging th...
|